Phase I repeat-dose study of resveratrol in colorectal cancer patients: tolerability, target tissue levels and pharmacodynamics
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Resveratrol (Primary)
- Indications Colorectal cancer
- Focus Biomarker; Pharmacodynamics
Most Recent Events
- 15 Sep 2014 Biomarkers information updated
- 02 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Mar 2007 New trial record.